Toward a <i>NOTCH1/FBXW7/RAS/PTEN</i> –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia StudyAmélie Trinquand, Vahid Asnafi, Ludovic Lhermitte et al.|Journal of Clinical Oncology|2013Cited by 252
Early Response–Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia StudyJonathan Bond, Vahid Asnafi, Carlos Graux et al.|Journal of Clinical Oncology|2017Cited by 171
<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemiaJonathan Bond, Nicolas Boissel, Aurore Touzart et al.|Haematologica|2019Cited by 63
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemiaLuke Jones, Jonathan Bond|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1